Theravance

Theravance

Theravance

Theravance develops small molecule medicines for respiratory disease, bacterial infections and gastrointestinal motility dysfunction.
Founded
1996
Raised
$129.4M
Follow us
Alexa global traffic share
Latest funding
$129,375,000
Private equity - 2010
GlaxoSmithKline
Team Size
200+
Employees
Xconomy

Theravance Snares $100M From Janssen in Stomach Drug Deal

Health
The Motley Fool

Why Theravance Inc. Vaulted 15% Higher in October --

Stock markets Earnings
The Motley Fool

Theravance Biopharma Inc Skyrocketed in October -- Here's Why --

Stock markets Health